Alpha Paradigm Partners’s Zimmer Biomet ZBH Stock Holding History

Alpha Paradigm Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,723	Closed	-$286K	–	655
2022 Q2	$286K	Sell	2,723 -2,600	-49%	-$308K	0.12%	267
2022 Q1	$681K	Sell	5,323 -2,349	-31%	-$283K	0.27%	113
2021 Q4	$946K	Buy	7,672 +2,816	+58%	+$369K	0.38%	63
2021 Q3	$690K	Buy	+4,856	New	+$714K	0.28%	116
2021 Q1	–	Sell	-995	Closed	-$149K	–	652
2020 Q4	$149K	Buy	+995	New	+$141K	0.05%	291

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha Paradigm Partners's ZBH Position: Q3 2022 in Review

Alpha Paradigm Partners sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 2,723 shares — an estimated $286K sold.

Alpha Paradigm Partners first reported a position in ZBH in Q4 2020 and held it in 5 quarters. The position peaked at $946K in Q4 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Alpha Paradigm Partners reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
Alpha Paradigm Partners sold 2,723 Zimmer Biomet shares in Q3 2022, an estimated $286K.
Alpha Paradigm Partners first reported a position in Zimmer Biomet in Q4 2020 and held it in 5 quarters.
Alpha Paradigm Partners's Zimmer Biomet position peaked at $946K in Q4 2021.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Alpha Paradigm Partners's 13F filing for Q3 2022, filed 15 Nov 2022.